Glentham will aim for a 'business as usual' approach for the EU market
Here we list the products that are currently being investigated for effectiveness against COVID-19
16 March 2020
COVID-19: Research & Candidates for Therapy
There are a number of research products supplied by Glentham Life Sciences that are thought to have therapeutic potential against COVID-19, or could help to limit further spread of the SARS-CoV-2 virus.
The following products are all listed and sold by Glentham for research purposes, and can be delivered next-day across Europe and North America:
GP4306 - Camostat mesylate (59721-29-8)
GA7477 - Chloroquine diphosphate salt (50-63-5)
GP6351 - Lopinavir (192725-17-0)
GP1071 - Remdesivir (1809249-37-3)
GA5462 - Ribavirin (36791-04-5)
GP3714 - Ritonavir (155213-67-5)
We will continue to update this list as more potential candidates are highlighted to us.
Last updated: 16/03/20
As a supplier of essential goods to the diagnostics industry and COVID-19 research, Glentham Life Sciences is to remain open as normal